Thioredoxin-interacting Protein (TXNIP) Mediates Thioredox-independent Antioxidant Mechanism in Endometrial Cancer Cells Treated With 1 alpha,25-dihydroxyvitamin D-3
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yesol | - |
dc.contributor.author | Kim, Yeon-Suk | - |
dc.contributor.author | Kim, Minjeong | - |
dc.contributor.author | Kim, Jun-Mo | - |
dc.contributor.author | Lee, Hae-Hyeog | - |
dc.contributor.author | Kim, Tae-Hee | - |
dc.date.accessioned | 2021-08-11T09:24:28Z | - |
dc.date.available | 2021-08-11T09:24:28Z | - |
dc.date.issued | 2019-09 | - |
dc.identifier.issn | 0250-7005 | - |
dc.identifier.issn | 1791-7530 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/4260 | - |
dc.description.abstract | Background/Aim: To determine the mechanism of vitamin D-3-induced modulation of antioxidant-related factors in endometrial cancer, we investigated their role in apoptosis of human endometrial cancer cells exposed to vitamin D-3. Materials and Methods: The survival rate of human endometrial cancer cells was estimated after treatment with activated vitamin D-3. Reactive oxygen species (ROS) levels were measured using flow cytometry. The levels of VDR, Trx, TXNIP and apoptosis-related proteins were investigated using western blotting and immunocytochemistry in human tissues. Results: Treatment with D-3 induced apoptotic cell death and cell-cycle arrest by increasing ROS concentration. Vitamin D-3 inhibited proliferation of human endometrial cancer cells. It regulated intracellular ROS concentration in endometrial cancer cells via increased TXNIP expression. Conclusion: Antioxidant regulation via TXNIP is an important cell death mechanism in human endometrial cancer, and occurs via induction by vitamin D-3. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | International Institute of Anticancer Research | - |
dc.title | Thioredoxin-interacting Protein (TXNIP) Mediates Thioredox-independent Antioxidant Mechanism in Endometrial Cancer Cells Treated With 1 alpha,25-dihydroxyvitamin D-3 | - |
dc.type | Article | - |
dc.publisher.location | 그리이스 | - |
dc.identifier.doi | 10.21873/anticanres.13664 | - |
dc.identifier.scopusid | 2-s2.0-85072155110 | - |
dc.identifier.wosid | 000486457600027 | - |
dc.identifier.bibliographicCitation | Anticancer Research, v.39, no.9, pp 4795 - 4803 | - |
dc.citation.title | Anticancer Research | - |
dc.citation.volume | 39 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 4795 | - |
dc.citation.endPage | 4803 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | VITAMIN-D | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | STATISTICS | - |
dc.subject.keywordPlus | DEFICIENCY | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | REGULATOR | - |
dc.subject.keywordPlus | TARGET | - |
dc.subject.keywordPlus | KOREA | - |
dc.subject.keywordPlus | VDUP1 | - |
dc.subject.keywordAuthor | Endometrial cancer | - |
dc.subject.keywordAuthor | vitamin D-3 | - |
dc.subject.keywordAuthor | thioredoxin | - |
dc.subject.keywordAuthor | thioredoxin-interacting protein | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.